TP53 and cancer: In p53-deficient cancer cells, SREBP2, activate the mevalonate pathway and increase ubiquinone levels in the body; ubiquinone is crucial for reducing oxidative stress and supporting pyrimidine nucleotide synthesis (Kaymak et al., 2020).